Related Experiment Video
Updated: Aug 16, 2026

Isolation, Behavioral Identification, and Pathogenicity Assessment of Entomopathogenic Fungi from a Forest Wood Borer
Published on: September 29, 2023
Dematiaceous fungi
1Dallas VA Medical Center, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA. sanjay.revankar@med.va.gov
Abstract:
Dematiaceous fungi are the etiologic agents of phaeohyphomycosis and are increasingly recognized as causing disease in humans. A wide variety of infectious syndromes are seen, from local infections due to trauma to widely disseminated infection in immunocompromised patients. Pulmonary disease may be divided into allergic bronchopulmonary and nonallergic syndromes, depending on the species. These fungi have unique pathogenic mechanisms owing to the presence of melanin in their cell walls, which imparts the characteristic dark color to their spores and hyphae. Melanin is a known virulence factor in certain fungi, including Cryptococcus neoformans and Wangiella dermatitidis. Therapy depends upon the clinical syndrome. Local infection may be cured with excision alone, whereas systemic disease is often refractory to therapy. Azoles such as itraconazole and voriconazole have the most consistent in vitro activity, though there is more clinical experience with itraconazole. Further studies are needed to better understand the pathogenesis and treatment of these uncommon infections.
Insights
Dematiaceous fungi cause phaeohyphomycosis, presenting diverse human infections. Melanin in their cell walls contributes to virulence, necessitating tailored treatments like azoles for effective management.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Dematiaceous fungi are increasingly identified as human pathogens causing phaeohyphomycosis.
- Infections range from localized traumatic to disseminated disease, particularly in immunocompromised individuals.
- Pulmonary manifestations include both allergic and non-allergic syndromes, species-dependent.
Purpose of the Study:
- To review the clinical spectrum of phaeohyphomycosis.
- To discuss the pathogenic mechanisms, focusing on melanin's role.
- To outline current therapeutic strategies and identify research needs.
Main Methods:
- Literature review of clinical cases and pathogenic studies.
- Analysis of fungal cell wall composition and virulence factors.
- Evaluation of antifungal susceptibility data and clinical treatment outcomes.
Main Results:
- Phaeohyphomycosis presents with varied clinical syndromes, from superficial to systemic infections.
- Melanin in fungal cell walls is a key virulence factor, influencing pathogenicity.
- Systemic infections are often refractory to treatment; azoles show consistent in vitro activity.
Conclusions:
- Dematiaceous fungi pose a significant and growing threat in human infectious diseases.
- Understanding melanin's role is crucial for developing targeted therapies.
- Further research is essential to improve treatment outcomes for phaeohyphomycosis.
Related Concept Videos
Fungal Phylum Basidiomycota
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Overview of Fungi
Fungal Phylum Microsporidia
Biodeterioration

